Suchergebnisse - "Sanchis-Gomar, Fabian"

PubPharm (530)

101

In reply-Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation : In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

enthalten in: Mayo Clinic proceedings | 2020

von Sanchis-Gomar, F. | Lavie, C. | Perez-Quilis, C. | +2

CommentOn: Mayo Clin Proc. 2020 Jun;95(6):1222-1230. - PMID 32376099

102

Should atrial fibrillation be considered a cardiovascular risk factor for a worse prognosis in COVID-19 patients?

enthalten in: European heart journal | 2020

von Sanchis-Gomar, F. | Perez-Quilis, C. | Lavie, C.

CommentOn: Eur Heart J. 2020 May 14;41(19):1821-1829. - PMID 32383763

103

Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?

enthalten in: Clinical chemistry and laboratory medicine | 2020

von Lippi, G. | Lavie, C. | Henry, B. | +1

104

Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?

enthalten in: Clinical chemistry and laboratory medicine | 2020

von Lippi, G. | Lavie, C. | Henry, B. | +1

105

Do genetic polymorphisms in angiotensin converting enzyme 2 (ACE2) gene play a role in coronavirus disease 2019 (COVID-19)?

enthalten in: Clinical chemistry and laboratory medicine | 2020

von Lippi, G. | Lavie, C. | Henry, B. | +1

106

Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19)

enthalten in: European journal of preventive cardiology | 2020

von Lippi, G. | Henry, B. | Sanchis-Gomar, F.

CommentIn: Acta Psychiatr Scand. 2020 May;141(5):399-400. - PMID 32324252

107

Antisense lipoprotein[a] therapy : State-of-the-art and future perspectives

enthalten in: European journal of internal medicine | 2020

von Lippi, G. | Favaloro, E. | Sanchis-Gomar, F.

108

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019

enthalten in: Mayo Clinic proceedings | 2020

von Sanchis-Gomar, F. | Lavie, C. | Perez-Quilis, C. | +2

CommentIn: Mayo Clin Proc. 2020 Jul;95(7):1552-1553. - PMID 32622456

109

COVID-19 : unravelling the clinical progression of nature's virtually perfect biological weapon

enthalten in: Annals of translational medicine | 2020

von Lippi, G. | Sanchis-Gomar, F. | Henry, B.

110

Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19)

enthalten in: Diagnosis (Berlin, Germany) | 2020

von Lippi, G. | Henry, B. | Bovo, C. | +1